返回期刊详情
T
The Lancet Diabetes & Endocrinology
IF
论文数24
被引数
期刊论文 23
发表时间
Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study一周一次卡格列汀–司美格鲁肽(CagriSema)在饮食和运动控制不佳的2型糖尿病成人中的疗效与安全性(REIMAGINE 1):一项随机、双盲、安慰剂对照的3a期研究

